Transactions 18
| X |
Filed |
Traded |
Ticker |
Company |
Insider |
Title |
Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
|
2026-02-18 |
2026-02-13 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
A - Grant |
$0.00 |
+200.0K |
308.9K |
+184% |
$0 |
| M |
2026-02-18 |
2026-02-13+ |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
M - OptEx |
$0.00 |
+25.9K |
307.1K |
+9% |
$0 |
| M |
2026-02-18 |
2026-02-13+ |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
F - Tax |
$1.89 |
-9,004 |
299.9K |
-3% |
-$17.0K |
| D |
2025-02-18 |
2025-02-14 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
A - Grant |
$0.00 |
+56.5K |
111.3K |
+103% |
$0 |
| DM |
2025-02-18 |
2025-02-13+ |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
F - Tax |
$3.19 |
-4,103 |
108.9K |
-4% |
-$13.1K |
| D |
2024-11-12 |
2024-11-07 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
M - OptEx |
— |
+3,750 |
57.6K |
+7% |
— |
| D |
2024-11-12 |
2024-11-07 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
F - Tax |
$6.04 |
-1,102 |
56.5K |
-2% |
-$6,656 |
| D |
2024-09-17 |
2024-09-16 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
M - OptEx |
— |
+2,250 |
54.5K |
+4% |
— |
| D |
2024-09-17 |
2024-09-16 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
F - Tax |
$6.36 |
-661 |
53.8K |
-1% |
-$4,204 |
| D |
2024-02-15 |
2024-02-14 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
A - Grant |
$0.00 |
+27.3K |
52.3K |
+109% |
$0 |
| D |
2024-02-15 |
2024-02-13 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
F - Tax |
$6.53 |
-1,735 |
25.0K |
-7% |
-$11.3K |
| D |
2023-08-31 |
2023-08-30 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
F - Tax |
$2.93 |
-661 |
26.7K |
-2% |
-$1,937 |
| D |
2023-08-31 |
2023-08-30 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
M - OptEx |
— |
+2,250 |
27.3K |
+9% |
— |
| D |
2023-02-15 |
2023-02-13 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
A - Grant |
$0.00 |
+20.0K |
25.1K |
+392% |
$0 |
| D |
2023-02-01 |
2023-01-30 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
M - OptEx |
— |
+3,750 |
6,398 |
+142% |
— |
| D |
2023-02-01 |
2023-01-30 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
F - Tax |
$7.78 |
-1,301 |
5,097 |
-20% |
-$10.1K |
| A |
2022-06-14 |
2022-05-26 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
F - Tax |
$7.01 |
-1,102 |
2,648 |
-29% |
-$7,725 |
| D |
2022-05-27 |
2022-05-25 |
CCCC |
C4 Therapeutics, Inc. |
Schick Kelly |
CHRO |
M - OptEx |
— |
+3,750 |
3,750 |
New |
— |
Purchase
Sale
Sale after option exercise
All abbreviations